Best TWAS P=4.12e-44 · Best GWAS P=3.17e-36 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ADCY3 | 0.16 | 0.12 | lasso | 10 | 0.14 | 3.2e-17 | 12.2 | -13.9 | 4.1e-44 | -0.87 | 0.01 | 0.99 | TRUE |
2 | CommonMind | Brain Pre-frontal Cortex | CENPO | 0.07 | 0.03 | bslmm | 322 | 0.03 | 7.0e-05 | 7.4 | -8.9 | 5.5e-19 | -0.49 | 0.46 | 0.29 | FALSE |
3 | GTEx | Adipose Subcutaneous | ADCY3 | 0.07 | 0.04 | lasso | 6 | 0.01 | 3.2e-02 | 11.0 | 10.4 | 1.6e-25 | 0.86 | 0.07 | 0.91 | FALSE |
4 | GTEx | Adipose Subcutaneous | RP11-443B20.1 | 0.04 | 0.00 | enet | 10 | 0.00 | 1.2e-01 | 7.1 | 9.2 | 5.5e-20 | 0.81 | 0.04 | 0.90 | TRUE |
5 | GTEx | Adrenal Gland | PTRHD1 | 0.32 | 0.28 | lasso | 3 | 0.26 | 8.3e-10 | -5.2 | 5.6 | 2.1e-08 | 0.41 | 0.98 | 0.00 | FALSE |
6 | GTEx | Artery Coronary | DNAJC27 | 0.12 | 0.03 | lasso | 7 | 0.00 | 2.4e-01 | 3.5 | 5.5 | 3.4e-08 | 0.46 | 0.14 | 0.22 | FALSE |
7 | GTEx | Artery Tibial | ADCY3 | 0.21 | 0.14 | lasso | 6 | 0.15 | 4.3e-12 | 10.7 | 11.9 | 2.1e-32 | 0.69 | 0.98 | 0.02 | FALSE |
8 | GTEx | Artery Tibial | RP11-443B20.1 | 0.17 | 0.08 | enet | 40 | 0.09 | 8.2e-08 | 10.7 | 10.5 | 1.1e-25 | 0.59 | 0.43 | 0.53 | FALSE |
9 | GTEx | Cells EBV-transformed lymphocytes | ADCY3 | 0.25 | 0.23 | enet | 10 | 0.12 | 9.2e-05 | 11.0 | -8.8 | 1.2e-18 | -0.84 | 0.02 | 0.97 | TRUE |
10 | GTEx | Cells EBV-transformed lymphocytes | RP11-443B20.1 | 0.13 | 0.13 | enet | 9 | 0.05 | 9.2e-03 | 11.0 | -11.3 | 9.1e-30 | -0.93 | 0.01 | 0.97 | FALSE |
11 | GTEx | Nerve Tibial | ADCY3 | 0.09 | 0.05 | enet | 6 | 0.03 | 2.2e-03 | 10.7 | -12.9 | 5.5e-38 | -0.91 | 0.02 | 0.98 | FALSE |
12 | GTEx | Nerve Tibial | RP11-443B20.1 | 0.07 | 0.03 | enet | 6 | 0.02 | 1.1e-02 | 10.7 | -12.6 | 2.3e-36 | -0.81 | 0.03 | 0.96 | FALSE |
13 | GTEx | Whole Blood | DNAJC27 | 0.08 | 0.10 | lasso | 1 | 0.10 | 2.2e-09 | 10.8 | 10.8 | 3.8e-27 | 0.80 | 0.91 | 0.09 | FALSE |
14 | GTEx | Whole Blood | ADCY3 | 0.23 | 0.24 | enet | 24 | 0.27 | 5.5e-25 | 11.1 | 12.2 | 2.0e-34 | 0.86 | 1.00 | 0.00 | FALSE |
15 | GTEx | Whole Blood | RP11-443B20.1 | 0.21 | 0.17 | enet | 32 | 0.20 | 1.8e-18 | 10.8 | 12.7 | 4.2e-37 | 0.86 | 0.79 | 0.21 | FALSE |
16 | METSIM | Adipose | EFR3B | 0.04 | 0.00 | bslmm | 357 | 0.00 | 9.7e-02 | -1.3 | -7.4 | 1.2e-13 | -0.37 | 0.06 | 0.08 | FALSE |
17 | ROSMAP | Brain Pre-frontal Cortex | ADCY3 | 0.17 | 0.26 | enet | 32 | 0.26 | 6.8e-33 | 11.1 | -12.2 | 2.3e-34 | -0.89 | 0.80 | 0.20 | FALSE |
18 | ROSMAP | Brain Pre-frontal Cortex | CENPO | 0.08 | 0.04 | enet | 5 | 0.05 | 2.6e-07 | -4.5 | -5.5 | 4.6e-08 | -0.36 | 1.00 | 0.00 | FALSE |
19 | YFS | Blood | ADCY3 | 0.07 | 0.02 | bslmm | 343 | 0.04 | 7.3e-14 | 12.5 | -7.7 | 1.2e-14 | -0.61 | 0.00 | 1.00 | FALSE |
20 | YFS | Blood | POMC | 0.35 | 0.05 | enet | 71 | 0.19 | 5.7e-59 | -8.0 | -7.3 | 2.7e-13 | -0.31 | 1.00 | 0.00 | FALSE |
21 | The Cancer Genome Atlas | Breast Invasive Carcinoma | POMC | 0.08 | 0.05 | lasso | 3 | 0.06 | 2.6e-12 | -3.0 | -6.9 | 5.3e-12 | -0.20 | 0.97 | 0.03 | TRUE |
22 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | POMC | 0.06 | 0.00 | enet | 12 | 0.03 | 9.3e-05 | -3.0 | -7.3 | 3.9e-13 | -0.27 | 0.01 | 0.41 | TRUE |
23 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | EFR3B | 0.03 | 0.05 | lasso | 1 | 0.04 | 1.9e-05 | -9.6 | -9.6 | 7.8e-22 | -0.67 | 0.56 | 0.06 | FALSE |
24 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | POMC | 0.16 | 0.05 | blup | 39 | 0.11 | 2.4e-12 | -8.0 | -5.2 | 2.7e-07 | -0.22 | 1.00 | 0.00 | TRUE |
25 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ADCY3 | 0.03 | 0.02 | blup | 81 | 0.02 | 7.1e-04 | 6.6 | -10.5 | 1.1e-25 | -0.87 | 0.04 | 0.93 | FALSE |
26 | The Cancer Genome Atlas | Lung Adenocarcinoma | DNAJC27 | 0.05 | 0.01 | blup | 46 | 0.04 | 3.2e-05 | 3.5 | -6.7 | 1.8e-11 | -0.55 | 0.34 | 0.60 | FALSE |
27 | The Cancer Genome Atlas | Lung Adenocarcinoma | POMC | 0.14 | 0.04 | enet | 7 | 0.08 | 5.3e-10 | -3.0 | -7.9 | 2.0e-15 | -0.22 | 0.38 | 0.62 | FALSE |
28 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | POMC | 0.19 | 0.01 | blup | 38 | 0.05 | 1.5e-04 | -8.0 | -6.8 | 7.3e-12 | -0.33 | 0.01 | 0.56 | TRUE |
29 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | POMC | 0.22 | 0.05 | blup | 37 | 0.03 | 2.1e-02 | -3.6 | -7.6 | 3.8e-14 | -0.12 | 0.01 | 0.29 | FALSE |
30 | The Cancer Genome Atlas | Prostate Adenocarcinoma | POMC | 0.11 | 0.08 | enet | 7 | 0.09 | 1.6e-09 | -3.0 | -7.8 | 5.4e-15 | -0.24 | 0.92 | 0.06 | FALSE |
31 | The Cancer Genome Atlas | Stomach Adenocarcinoma | POMC | 0.14 | 0.00 | blup | 40 | 0.02 | 2.2e-02 | -3.6 | -5.7 | 1.0e-08 | -0.14 | 0.01 | 0.18 | TRUE |